Contrary to the case with bacterial infections, progress in the diagnosis and treatment of
invasive mycoses in cancer patients has been unsatisfactory. Amphotericin B deoxycholate …

Fungi are becoming a serious public health hazard, especially for the growing numbers of
immunocompromised patients in hospitals. These numbers will only increase and cancer …

The incidence of invasive fungal infection has increased in recent years. Most infections are
caused by Candida albicans and Aspergillus spp. but the emergence of other fungal …

Abstract The Infectious Diseases Working Party (AGIHO) of the German Society of
Hematology and Oncology (DGHO) here presents its updated recommendations for the …

The increasing incidence and severity of invasive mycoses have led to the development of
new strategies with new antifungal agents, and amphotericin B no longer is the gold …

Over the last decade, with increasing use of aggressive chemotherapy and bone marrow
transplantation in the treatment of cancer, fungi have emerged as a major pathogen. The …

The management of invasive fungal infections in immunocompromised patients with cancer
remains controversial in several respects. There has been a steady and alarming increase …

Medical mycology has always been somewhat overshadowed by bacteriology, and if judged
simply by volume will never reach the status of its big sister in the field of infectious diseases …

Fungal infections in the immunocompromised cancer patient may threaten survival and
represent a major therapeutic challenge. Granulocytopenia, especially, increases the risk of …

Invasive fungal infections have emerged as important causes of morbidity and mortality in
profoundly immunocompromised patients with cancer. Current treatment strategies for these …